MTD
Mettler-Toledo InternationalBNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
Composite grade B from latest DB weights. Momentum 54.2 / Value 61.8
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
54
Value
62
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $1,348.91
Why
Momentum54 · Δ7d +41.2
Value62 · Δ7d +0.1
SentimentN/A · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
54
40% active weight
Current posture
7d trendImproving
Δ7d
+41.2
Δ21d
+39.2
Value
62
60% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 54.2 / Value 61.8
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$25.74B
Beta
1.43
Shares Out
20.21M
P/E (TTM)
36.1
P/S (TTM)
7.50
P/FCF (TTM)
33.22
Rev YoY
+7.2%
EPS YoY
+6.7%
Gross Margin
+57.3%
Op Margin
+26.2%
Net Debt
$2.2B
Current Ratio
1.20
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology